Literature DB >> 12121644

Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate.

Elena S Stavridi1, Yentram Huyen, Ivy R Loreto, Daniel M Scolnick, Thanos D Halazonetis, Nikola P Pavletich, Philip D Jeffrey.   

Abstract

The Chfr mitotic checkpoint protein is frequently inactivated in human cancer. We determined the three-dimensional structure of its FHA domain in its native form and in complex with tungstate, an analog of phosphate. The structures revealed a beta sandwich fold similar to the previously determined folds of the Rad53 N- and C-terminal FHA domains, except that the Rad53 domains were monomeric, whereas the Chfr FHA domain crystallized as a segment-swapped dimer. The ability of the Chfr FHA domain to recognize tungstate suggests that it shares the ability with other FHA domains to bind phosphoproteins. Nevertheless, differences in the sequence and structure of the Chfr and Rad53 FHA domains suggest that FHA domains can be divided into families with distinct binding properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121644     DOI: 10.1016/s0969-2126(02)00776-1

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  18 in total

1.  NMR structure of the forkhead-associated domain from the Arabidopsis receptor kinase-associated protein phosphatase.

Authors:  Gui-In Lee; Zhaofeng Ding; John C Walker; Steven R Van Doren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

2.  Open interface and large quaternary structure movements in 3D domain swapped proteins: insights from molecular dynamics simulations of the C-terminal swapped dimer of ribonuclease A.

Authors:  Antonello Merlino; Marc Antoine Ceruso; Luigi Vitagliano; Lelio Mazzarella
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

3.  PhosphoThr peptide binding globally rigidifies much of the FHA domain from Arabidopsis receptor kinase-associated protein phosphatase.

Authors:  Zhaofeng Ding; Gui-in Lee; Xiangyang Liang; Fabio Gallazzi; A Arunima; Steven R Van Doren
Journal:  Biochemistry       Date:  2005-08-02       Impact factor: 3.162

4.  Partially unfolded forms and non-two-state folding of a beta-sandwich: FHA domain from Arabidopsis receptor kinase-associated protein phosphatase.

Authors:  Xiangyang Liang; Gui-in Lee; Steven R Van Doren
Journal:  J Mol Biol       Date:  2006-09-03       Impact factor: 5.469

5.  The NMR structure of the NIPP1 FHA domain.

Authors:  Hiroyuki Kumeta; Kenji Ogura; Souichirou Adachi; Yuko Fujioka; Nobuhiro Tanuma; Kiminobu Tanuma; Kunimi Kikuchi; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2008-02-06       Impact factor: 2.835

Review 6.  Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.

Authors:  N K Bernstein; F Karimi-Busheri; A Rasouli-Nia; R Mani; G Dianov; J N M Glover; M Weinfeld
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

Review 7.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

8.  Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR).

Authors:  Jasmeen Oberoi; Mark W Richards; Simon Crumpler; Nathan Brown; Julian Blagg; Richard Bayliss
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

9.  Chfr is linked to tumour metastasis through the downregulation of HDAC1.

Authors:  Young Mi Oh; Young Eun Kwon; Joo Mi Kim; Sung Jun Bae; Bo Keun Lee; Soon Ji Yoo; Chin Ha Chung; Raymond J Deshaies; Jae Hong Seol
Journal:  Nat Cell Biol       Date:  2009-02-01       Impact factor: 28.824

10.  Direct kinase-to-kinase signaling mediated by the FHA phosphoprotein recognition domain of the Dun1 DNA damage checkpoint kinase.

Authors:  Vladimir I Bashkirov; Elena V Bashkirova; Edwin Haghnazari; Wolf-Dietrich Heyer
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.